| Title |
Author(s) |
Journal |
Issue Date |
Type |
|
Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial
|
Mavoko, H. M.; Nabasumba, C.; da Luz, R. I.; Tinto, H.; D'Alessandro, U.; Kambugu, A.; Baraka, V.; Rosanas-Urgell, A.; Lutumba, P.; Van geertruyden, J. P.
|
Lancet Global Health |
2017
|
Article-E
|
|
Paediatric pharmacovigilance: use of pharmacovigilance data mining algorithms for signal detection in a safety dataset of a paediatric clinical study conducted in seven African countries
|
Kajungu, D. K.; Erhart, A.; Talisuna, A. O.; Bassat, Q.; Karema, C.; Nabasumba, C.; Nambozi, M.; Tinto, H.; Kremsner, P.; Meremikwu, M.; D'Alessandro, U.; Speybroeck, N.
|
PLoS ONE |
2014
|
Article-E
|
|
Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria
|
Van Malderen, C.; Van geertruyden, J. P.; Machevo, S.; Gonzalez, R.; Bassat, Q.; Talisuna, A.; Yeka, A.; Nabasumba, C.; Piola, P.; Daniel, A.; Turyakira, E.; Forret, P.; Van Overmeir, C.; van Loen, H.; Robert, A.; D'Alessandro, U.
|
Malaria Journal |
2012
|
Article-E
|